Pershing Square Capital
View Older Stories View More Recent Stories
-
Pershing Square Submits Additional Requests for Allergan (AGN) Special Meeting
-
Pershing Square Submits Additinal Special Meeting Requests to 1.29% of Allergan (AGN) Shareholders
-
Allergan (AGN) Comments on Pershing's Delivery of Additional Shareholder Requests; Reaffirms Value Stance (VRX)
-
Allergan (AGN) Updates on Validity of Pershing Square's Delivery of Written Requests
-
UPDATE: Valeant Pharma (VRX), Pershing Square Win Bid to Fast-Track Allergan (AGN) Suit
-
Allergan (AGN) Requests Expedited Schedule for Prelim. Injunction Against Valeant (VRX), Pershing Square
-
Allergan (AGN) Special Meeting Set for Dec. 18 - Bloomberg
-
Allergan (AGN) Affirms Receipt of Special Meeting Request from Pershing Square (VRX)
-
Ackman's Pershing Square Approved to Call Special Meeting of Allergan (AGN) Shareholders (VRX)
-
Allergan (AGN) Approached Salix Pharma (SLXP) - DJ
-
Pershing Square Says 'Toehold' in Allergan (AGN) Wasn't Illegal
-
UPDATE: Valeant Pharma (VRX): SEC Investigating Valeant /Pershing Bid for Allergan (AGN) - DJ
-
Valeant Pharmaceuticals (VRX), Pershing Call Allergan (AGN) Lawsuit Frivolous
-
Allergan (AGN) Files Complaint Against Valeant (VRX), Pershing Square; Alleges Violation of Securities Laws
-
Allergan (AGN) CEO Pyott: We're Looking to Do Our Own Acquisitions (VRX) (SHPG)
-
Pershing Square Files Solicitation For Special Meeting of Allergan (AGN) Shareholders
-
Pershing Square Taps Top Global Bank in Effort to Bring Valeant (VRX) and Allergan (AGN) Together
-
Valeant Pharma (VRX) on Watch Following Pershing Square, Allergan (AGN) Suit Settlement
-
Valeant Pharma (VRX) CEO Says Allergan (AGN) Shareholders Support Meeting on Takeover
-
Shire plc (SHPG) Hires Goldman as Adviser - NYT
-
Allergan (AGN) Rejects Unsolicited Exchange Offer from Valeant (VRX)
-
Pershing's Lawsuit Against Alergan (AGN) Fast-Tracked - WSJ
-
Valeant Pharma (VRX) Announces Commencement of Allergan (AGN) Exchange Offer
-
Pershing Square Files Lawsuit Against Allergan (AGN) to Confirm Special Meeting Will Not Trigger Poison Pill
-
Market Wrap: BE Aerospace Plans Split; Valeant, Pershing Square Rejected; New AIG Boss
-
Notable Mergers and Acquisitions of the Day 06/10: (AGN)/(VRX) (BEAV) (PPL) (CLSN)
-
Allergan (AGN) Rejects Revised Offer from Pershing Square, Valeant (VRX)
-
Market Wrap: Apple Debuts New Software, Apps; Broadcom Looks to Exit BaseBand Business
-
Valeant Pharmaceuticals (VRX) PT Raised to $209 at Cantor Fitzgerald
-
Allergan, Inc. (AGN) Responds Pershing Square's Proxy Filing
-
Valeant Pharmaceuticals (VRX), Pershing Square Revise Offer for Allergan; Now $72/Share Cash, 0.82 of Valeant Stock
-
Pershing Square Says Allergan (AGN) Needs Independent Counsel
-
Pershing Square Sends Letter to Allergan, Inc. (AGN); Sees Fault in Rejecting Valeant (VRX) Offer
-
Top 10 News for 04/21 - 04/25: Valeant Makes Big Acquisition; EPS Galore; Netflix Mulls Price Hike
-
Deals, Deals, Deals in Pharmaceutical Sector; Who's Next?
-
Pre-Open Movers 4/22: (RVNC) (AGN) (NFLX) Higher; (MDSO) (BEBE) (RMBS) Lower (more...)
-
Valeant's (VRX) Move to Acquire Allergan (AGN) Makes Sense on Several Fronts - Aegis Capital
-
Jefferies Starts Valeant Pharmaceuticals (VRX) at Buy
-
Valeant (VRX) Enters Cash, Stock Bid for Allergan (AGN)
-
Allergan, Inc. (AGN) Issues Statement on Purported Valeant and Pershing Square Offer
-
After-Hours Movers 4/21: (AGN) (VRX) (NFLX) Higher; (RMBS) (CDNS) (ALSN) Lower (more...)
-
Market Wrap: Next Ford CEO Speculated; Gold Merger Tarnishes; Sarepta Pops on DMD Treatment Timeline
-
Bill Ackman Confirms Valeant (VRX) Merger Plans on Allergan (AGN) - 13D
-
Allergan, Inc. (AGN) Surges on Ackman, Valeant Takeover Interest

